Page 660 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

638 PART IV Specific Malignancies in the Small Animal Patient

30. Vascellari M, Carminato A, Camall G, et al.: Malignant mesothe- 53. Lee CH, Kweon OK: Mutations of p53 tumor suppressor
lioma of the tunica vaginalis testis in a dog: histological and immu- gene in spontaneous canine mammary tumors, J Vet Sci 3:
nohistochemical characterization, J Vet Diagn Invest 23:135–139, 321–325, 2002.
VetBooks.ir 31. Scully RE, Coffin DL: Canine testicular tumors with special refer- 54. Queiroga FL, Raposo T, Carvalho MI, et al.: Canine mammary
2011.
tumours as a model to study human breast cancer: most recent
findings, In Vivo 25:455–465, 2011.
ence to their histogenesis, comparative morphology, and endocri-
nology, Cancer Epidemiol Biomarkers Prev 5:592–605, 1952. 55. Inoue M, Wada N: Immunohistochemical detection of p53
32. Lipowitz AJ, Schwartz A, Wilson GP, et al.: Testicular neoplasms and p21 proteins in canine testicular tumours, Vet Rec 146:
and concomitant clinical changes in the dog, J Am Vet Med Assoc 370–372, 2000.
163:1364–1368, 1973. 56. Vitellozzi G, Mariotti F, Ricci G: Immunohistochemical expres-
33. Hohsteter M, Artukovic B, Severin K, et al.: Canine testicular sion of the p53 protein in testicular tumours in the dog, Eur J Vet
tumors: two types of seminomas can be differentiated by immuno- Pathol 4:61–65, 1998.
histochemistry, BMC Vet Res 10(169), 2014. 57. Restucci B, Maiolino P, Paciello O, et al.: Evaluation of angiogen-
34. Priester WA, McKay FW: The occurrence of tumors in domestic esis in canine seminomas by quantitative immunohistochemistry,
animals, Natl Cancer Inst Monogr 54:1–210, 1980. J Comp Pathol 128:252–259, 2003.
35. Sapierzynski R, Malicka E, Bielecki W, et al.: Tumors of the uro- 58. Yoshinaga K, Nishikawa S, Ogawa M, et al.: Role of c-kit in mouse
genital system in dogs and cats. Retrospective review of 138 cases, spermatogenesis: identification of spermatogonia as a specific site of
Pol J Vet Sci 10:97–103, 2007. c-kit expression and function, Development 113:689–699, 1991.
36. Hayes HM, Tarone RE, Casey HW: A cohort study of the effects 59. Sattler M, Salgia R: Targeting c-kit mutation: basic science to novel
of Vitenam service on testicular pathology of US military working therapies, Leuk Res 28S1:S11–S20, 2004.
dogs, Mil Med 160:248–255, 1995. 60. Goddard NC, McIntyre A, Summersgill B, et al.: KIT and RAS
37. Hayes HM, Tarone RE, Casey HW, et al.: Excess of seminomas signalling pathways in testicular germ cell tumours: new data and a
observed in Vietnam service U.S. military working dogs, J Natl review of the literature, Int J Androl 30:337–348, 2007.
Cancer Inst 82:1042–1046, 1990. 61. Mauduit C, Hamamah S, Benahmed M: Stem cell factor/c-kit sys-
38. McEntee MC: Reproductive oncology, Clin Tech Sm Anim Pract tem in spermatogenesis, Hum Reprod Update 5:535–545, 1999.
17:133–149, 2002. 62. Rothschild G, Sottas CM, Kissel H, et al.: A role for kit recep-
39. Benazzi C, Sarli G, Preziosi R, et al.: Laminin expression in testicu- tor signaling in Leydig cell steroidogenesis, Biol Reprod 69:
lar tumours of the dog, J Comp Pathol 112:141–150, 1995. 925–932, 2003.
40. Sarli G, Benazzi C, Preziosi R, et al.: Proliferative activity assessed 63. Grieco V, Banco B, Giudice C, et al.: Immunohistochemical
by anti-PCNA and Ki67 Mabs in canine testicular tumours, expression of the KIT protein (CD117) in normal and neoplastic
J Comp Pathol 110:357–368, 1994. canine testes, J Comp Pathol 142:213–217, 2010.
41. Papaioannou N, Psalla D, Zavlaris M, et al.: Immunohistochemical 64. Stoop H, Honecker F, vandeGeijn GJ, et al.: Stem cell factor as
expression of dogTERT in canine testicular tumours in relation to a novel diagnostic marker for early malignant germ cells, J Pathol
PCNA, ki67 and p53 expression, Vet Res Commun 33:905–919, 216:43–54, 2008.
2009. 65. Cummings OW, Ulbright TM, Eble JN, et al.: Spermatocytic
42. Nasir L: Telomeres and telomerase: biological and clinical impor- seminoma: an immunohistochemical study, Hum Pathol 25:54–59,
tance in dogs, Vet J 175:155–163, 2008. 1994.
43. DeVico G, Papparella S, DiGuardo G: Number and size of sliver- 66. Bush JM, Gardiner DW, Palmer JS, et al.: Testicular germ cell
stained nucleoli (Ag-NOR clusters) in canine seminomas: corre- tumours in dogs are predominantly of spermatocytic seminoma
lation with histological features and tumour behaviour, J Comp type and are frequently associated with somatic cell tumours, Int J
Pathol 110:267–273, 1994. Androl 34:e288–e295, 2011.
44. Nasir L, Devlin P, McKevitt T, et al.: Telomere lengths and telom- 67. Thorvaldsen TE, Nodtvedt A, Grotmol T, et al.: Morphological
erase activity in dog tissues: a potential model system to study and immunohistochemical characterisation of seminomas in Nor-
human telomere and telomerase biology, Neoplasia 3:351–359, wegian dogs, Acta Vet Scand 54:52, 2012.
2001. 68. Hogenesch H, Whitely HE, Vicini DS, et al.: Seminoma with
45. Murakami Y, Tateyama S, Uchida K, et al.: Immunohistochemical metastases in the eyes and the brain in a dog, Vet Pathol 24:278–
analysis of cyclins in canine normal testes and testicular tumors, 280, 1987.
J Vet Med Sci 63:909–912, 2001. 69. Brodey RS, Martin JE: Sertoli cell neoplasms in the dog: the clini-
46. Brehm R, Ruttinger C, Fischer P, et al.: Transition from preinvasive copathological and endocrinological findings in thirty-seven dogs,
carcinoma in situ to seminoma is accompanied by a reduction of J Am Vet Med Assoc 133:249–257, 1958.
connexin 43 expression in Sertoli cells and germ cells, Neoplasia 70. Dhaliwal RS, Kitchell BE, Knight BL, et al.: Treatment of aggres-
8:499–509, 2006. sive testicular tumors in four dogs, J Am An Hosp Assoc 35:311–
47. Lin JH, Takano T, Cotrina ML, et al.: Connexin 43 enhances the 318, 1999.
adhesivity and mediates the invasion of malignant glioma cells, 71. Spugnini EP, Bartolazzi A, Ruslander D: Seminoma with cutane-
J Neurosci 22:4302–4311, 2002. ous metastases in a dog, J Am An Hosp Assoc 36:253–256, 2000.
48. Risley MS, Tan IP, Roy C, et al.: Cell-, age-, and stage-dependent 72. Takiguchi M, Iida T, Kudo T, et al.: Malignant seminoma with
distribution of connexin43 gap junctions in testes, J Cell Sci 103: systemic metastases in a dog, J Sm An Pract 42:360–362, 2001.
81–96, 1992. 73. Weller RE, Palmer B: Metastatic seminoma in a dog, Mod Vet Pract
49. Steger K, Tetens F, Bergmann M: Expression of connexin43 in 64:275–278, 1983.
human testis, Histochem Cell Biol 112:215–220, 1999. 74. Gopinath D, Draffan D, Philbey AW, et al.: Use of intral-
50. Zhang W, Nwagwu C, Le DM, et al.: Increased invasive capac- esional oestradiol concentration to identify a functional pulmo-
ity of connexin43-overexpressing malignant glioma cells, J Neurosci nary metastasis of canine sertoli cell tumor, J Sm An Pract 50:
99:1039–1046, 2003. 198–200, 2009.
51. Ruttinger C, Bergmann M, Fink L, et al.: Expression of connexin 75. Morgan RV: Blood dyscrasias associated with testicular tumors in
43 in normal canine testes and canine testicular tumors, Histochem the dog, J Am An Hosp Assoc 18:970–975, 1982.
Cell Biol 130:537–548, 2008. 76. Mischke R, Meurer D, Hoppen HO, et al.: Blood plasma concen-
52. Lee CH, Kim WH, Lim JH, et al.: Mutation and overexpression trations of oestradiol-17B, testosterone and testosterone/oestradiol
of p53 as a prognostic factor in canine mammary tumors, J Vet Sci ratio in dogs with neoplastic and degenerative testicular diseases,
5:63–69, 2004. Res Vet Sci 73:267–272, 2002.